W/O/W multiple emulsions of insulin containing a protease inhibitor and an absorption enhancer: biological activity after oral administration to normal and diabetic rats

被引:43
作者
Silva-Cunha, A
Cheron, M
Grossiord, JL
Puisieux, F
Seiller, M
机构
[1] Pharm Galen & Biopharm Lab, URA CNRS 1218, UFR Sci Pharmaceut, F-92296 Chatenay Malabry, France
[2] Lab Phys Pharmaceut, UFR Sci Pharmaceut, F-92296 Chatenay Malabry, France
[3] Univ Pierre & Marie Curie, CNRS URA 2056, Lab Physicochim Biomol & Cellulaire, F-75252 Paris, France
关键词
W/O/W multiple emulsion; insulin; protease inhibitor; absorption enhancer; oral route; diabetic and normal rats; glycemia;
D O I
10.1016/S0378-5173(98)00102-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this work, the biological effects of w/o/w multiple emulsions of medium-chain triglycerides containing sodium insulin alone or with a protease inhibitor, or with an absorption enhancer, or with a protease inhibitor and an absorption enhancer, were compared to a w/o/w multiple emulsion containing zinc insulin. The release mechanism of all multiple emulsions was the swelling-breakdown phenomenon after dilution of the emulsions under hypo-osmotic conditions. The biological effects after oral administration to normal and diabetics rats showed a larger decrease of glycemia with the multiple emulsions containing sodium insulin than with the multiple emulsion containing zinc insulin. However, there was no significant difference between the hypoglycemic effects induced by the emulsions containing sodium insulin. These results suggest that the aggregation state of insulin molecules might be the major factor responsible for increasing the extent of intestinal insulin absorption. Thus, the nature of the insulin plays a fundamental role and, at the concentration used in this work, the addition of sodium taurocholate was not able to modify its aggregation state in aqueous solution, as confirmed by circular dichroism studies. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:33 / 44
页数:12
相关论文
共 19 条
[1]   SITE DEPENDENCE OF ABSORPTION-PROMOTING ACTIONS OF LAURETH-9, NA SALICYLATE, NA2EDTA, AND APROTININ ON RECTAL, NASAL, AND BUCCAL INSULIN DELIVERY [J].
AUNGST, BJ ;
ROGERS, NJ .
PHARMACEUTICAL RESEARCH, 1988, 5 (05) :305-308
[2]   MORPHO-CYTOCHEMICAL AND BIOCHEMICAL-EVIDENCE FOR INSULIN ABSORPTION BY THE RAT ILEAL EPITHELIUM [J].
BENDAYAN, M ;
ZIV, E ;
BENSASSON, R ;
BARON, H ;
KIDRON, M .
DIABETOLOGIA, 1990, 33 (04) :197-204
[3]   NEW APPROACH FOR ORAL-ADMINISTRATION OF INSULIN WITH POLYALKYLCYANOACRYLATE NANOCAPSULES AS DRUG CARRIER [J].
DAMGE, C ;
MICHEL, C ;
APRAHAMIAN, M ;
COUVREUR, P .
DIABETES, 1988, 37 (02) :246-251
[4]   A CASE FOR ORAL INSULIN THERAPY IN THE PREVENTION OF DIABETIC MICROANGIOPATHY AND MACROANGIOPATHY [J].
GWINUP, G ;
ELIAS, AN ;
VAZIRI, ND .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1990, 13 (07) :393-395
[5]  
HIRAI S, 1981, INT J PHARM, V9, P173
[6]   THE ABSORPTION OF INSULIN FROM VARIOUS REGIONS OF THE RAT INTESTINE [J].
KIDRON, M ;
BARON, H ;
BERRY, EM ;
ZIV, E .
LIFE SCIENCES, 1982, 31 (25) :2837-2841
[7]   DISSOCIATION OF INSULIN OLIGOMERS BY BILE-SALT MICELLES AND ITS EFFECT ON ALPHA-CHYMOTRYPSIN-MEDIATED PROTEOLYTIC DEGRADATION [J].
LI, YP ;
SHAO, ZZ ;
MITRA, AK .
PHARMACEUTICAL RESEARCH, 1992, 9 (07) :864-869
[8]   INFLUENCE OF APROTININ ON INSULIN ABSORPTION AND SUBCUTANEOUS BLOOD-FLOW IN TYPE-1 (INSULIN-DEPENDENT) DIABETES [J].
LINDE, B ;
GUNNARSSON, R .
DIABETOLOGIA, 1985, 28 (09) :645-648
[9]   INSULIN AGGREGATION IN AQUEOUS-MEDIA AND ITS EFFECT ON ALPHA-CHYMOTRYPSIN-MEDIATED PROTEOLYTIC DEGRADATION [J].
LIU, FY ;
KILDSIG, DO ;
MITRA, AK .
PHARMACEUTICAL RESEARCH, 1991, 8 (07) :925-929
[10]   HYPOGLYCEMIC EFFECT OF NOVEL ORAL MICROSPHERES OF INSULIN WITH PROTEASE INHIBITOR IN NORMAL AND DIABETIC RATS [J].
MORISHITA, I ;
MORISHITA, M ;
TAKAYAMA, K ;
MACHIDA, Y ;
NAGAI, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 78 (01) :9-16